ArticleRSC advances2026
Application of multilayer drug-loaded hydrogels in protection of open abdomen wounds.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Open abdomen (OA) therapy is crucial for managing severe abdominal infections, intra-abdominal hypertension, and trauma but often faces complications like infections and enteric fistulas. To address this, a novel multilayer drug-loaded hydrogel dressing was designed to promote wound healing. The dressing comprises a bottom layer of a carboxymethyl chitosan/aldehyde-modified hyaluronic acid (CC/HA-CHO) hydrogel loaded with Ag nanoparticles (AgNPs) for rapid gelation and broad-spectrum antibacterial action; a middle polyacrylamide (PAAm) gel layer loaded with interleukin-4 (IL-4) to polarize macrophages toward the M2 phenotype for tissue repair; and a top polydimethylsiloxane (PDMS) antifouling layer treated with oxygen plasma for enhanced adhesion and hydrophilicity. Characterization
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.